有關1-乙基-7-(2-甲基-6-(1H-1，2，4-三唑-3-基)吡啶-3-基)-3，4-二氫吡嗪並[2，3-b]吡嗪-2(1H)-酮的藥物製劑、程序、固體形式和使用方法

• 收藏
• 分享

专利权人:

Signal Pharmaceuticals LLC

发明人:

MENON, Anil,PARIKH, Darshan, K. K,VISKY, Dora,KREILEIN, Matthew, Michael,BOERSEN, Nathan,LEE, Thomas,LI, Ying,XU, Jean,LIANG, Xiaozhang,LEONG, William, Wei-Hwa -,COHEN, Benjamin,本杰明．科恩,阿尼爾.門諾,達爾尚.,.帕瑞克,多拉.維斯基,馬修.邁克爾.克雷萊茵,內森.波爾森,托馬斯.李,李英,珍.徐,LEONG, W

申请号：

HK16109682.6

公开号：

HK1221951A

申请日:

2016.08.12

申请国别(地区):

HK

年份:

2017

代理人:

摘要：

The present invention relates to a pharmaceutical composition comprising 1-ethyl-7-(2-methyl-6-(4H-1,2,4-triazol-3-yl)pyridin-3-yl)-3,4-dihydropyrazino[2,3-b]pyrazin-2(1H)-one, or a pharmaceutically acceptable salt, tautomer, isotopologue or stereoisomer thereof and one or more pharmaceutically acceptable excipients or carriers. The present invention also relates to said composition for use in methods of treating various cancers.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/